JOHNSON KENNETH ERLAND

CIK 00017437742 companiesCHICAGO, IL

SEC Profile

Transactions

Companies

Filings

CIK

0001743774

Recent Transactions

41 trades

Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2025-01-31$3.56/sh−15,476→ 346,288 total
Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2025-01-31$3.56/sh−25,842→ 320,446 total
Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2025-01-03$3.61/sh−12,401→ 361,764 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2024-01-31+175,000→ 446,860 total
Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2024-01-31$2.46/sh−15,131→ 373,036 total
Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2024-01-29$2.66/sh−10,747→ 388,167 total
Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2024-01-03$2.24/sh−12,400→ 398,914 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2023-01-31+100,000→ 269,783 total
Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2023-01-31$1.24/sh−3,393→ 411,314 total
Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2023-01-29$1.26/sh−11,029→ 414,707 total
Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2023-01-03$1.12/sh−12,400→ 425,736 total
Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2022-01-31$2.11/sh−2,307→ 438,136 total
Tax Payment
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2022-01-29$2.11/sh−7,497→ 440,443 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2022-01-03+75,000→ 165,865 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2021-10-05+5,280→ 5,280 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2021-10-05+33,686→ 33,686 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2021-10-05+32,500→ 32,500 total
Disposition to Issuer
XERIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2021-10-05−33,686→ 0 total
Disposition to Issuer
XERIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2021-10-05−39,633→ 0 total
Disposition to Issuer
XERIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2021-10-05−32,500→ 0 total
Disposition to Issuer
XERIS PHARMACEUTICALS INC
Common Stock
2021-10-05−11,250→ 78,333 total
Disposition to Issuer
XERIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2021-10-05−5,280→ 0 total
Disposition to Issuer
XERIS PHARMACEUTICALS INC
Common Stock
2021-10-05−78,333→ 0 total
Disposition to Issuer
XERIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2021-10-05−21,401→ 0 total
Disposition to Issuer
XERIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2021-10-05−100,000→ 0 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2021-10-05+21,401→ 21,401 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2021-10-05+78,333→ 89,583 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2021-10-05+39,633→ 39,633 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2021-10-05+11,250→ 11,250 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2021-10-05+100,000→ 100,000 total
Award
XERIS PHARMACEUTICALS INC
Common Stock
2021-01-29+65,000→ 91,890 total
Award
XERIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2020-08-14+100,000→ 100,000 total
Award
XERIS PHARMACEUTICALS INC
Common Stock
2020-06-30$2.26/sh+775→ 26,890 total
Purchase
XERIS PHARMACEUTICALS INC
Common Stock
2020-02-14$4.15/sh+2,410→ 6,115 total
Award
XERIS PHARMACEUTICALS INC
Common Stock
2020-01-31+20,000→ 26,115 total
Award
XERIS PHARMACEUTICALS INC
Common Stock
2019-12-31$5.99/sh+286→ 3,705 total
Award
XERIS PHARMACEUTICALS INC
Common Stock
2019-07-01$9.72/sh+174→ 3,419 total
Purchase
XERIS PHARMACEUTICALS INC
Common Stock
2019-02-19$10.00/sh+1,000→ 3,245 total
Award
XERIS PHARMACEUTICALS INC
Stock Option (right to buy)
2019-01-31+32,500→ 32,500 total
Conversion
XERIS PHARMACEUTICALS INC
Series C Preferred Stock
2018-06-25−4,000→ 0 total
Conversion
XERIS PHARMACEUTICALS INC
Common Stock
2018-06-25+2,245→ 2,245 total

Companies

Recent Filings

Address

C/O XERIS BIOPHARMA HOLDINGS, INC. 1375 WEST FULTON STREET, SUITE 1300

CHICAGO, IL, 60607

View on SEC.gov